Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Bayer CropScience Limited, founded in Thane, India, in 1958, is a diversified enterprise involved in various sectors, including agriculture, pharmaceuticals, and consumer health, with a global reach encompassing India, Germany, and Bangladesh, among other international markets. The company's agricultural segment is dedicated to the manufacturing, sales, and distribution of an extensive array of crop protection products, such as insecticides, fungicides, and herbicides, alongside other specialized agrochemicals. It also provides hybrid seeds, including corn and paddy varieties, to agriculturalists. In the pharmaceutical domain, Bayer CropScience delivers medicines primarily targeting cardiology, gynecology, diabetes, oncology, and ophthalmology. Additionally, it supplies advanced diagnostic imaging technologies, such as computed tomography (CT), X-ray, and magnetic resonance imaging (MRI) equipment, together with essential contrast agents. Its consumer health division offers a selection of products designed for daily wellness and the management of minor ailments. Pioneering digital solutions for farming, the company provides platforms like FarmRiseTM and other predictive systems. These tools integrate and analyze vast amounts of data from sources such as farm machinery, satellites, field sensors, irrigation networks, and drones. Leveraging data science and sophisticated predictive analytics, these systems furnish farmers with actionable insights to optimize their decision-making. The company also actively exports its comprehensive range of products.
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair value on
Target Price
The average target price of BAYERCROP.NS is 5515 and suggests 30.3% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation